Usana Health Sciences (USNA) Depreciation & Amortization (CF) (2011 - 2026)

Usana Health Sciences (USNA) has reported Depreciation & Amortization (CF) for 16 consecutive years, with $8.3 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) fell 0.74% year-over-year to $8.3 million; the TTM figure through Apr 2026 stood at $32.5 million (up 64.81% YoY), while the FY2026 annual figure was $32.6 million, up 123.96% from the prior year.
• Depreciation & Amortization (CF) fell to $8.3 million in Q2 2026 per USNA's latest filing, from $8.6 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $8.6 million in Q1 2026 and bottomed at $2.5 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $4.7 million across 5 years, with a median of $3.4 million in 2022.
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) retreated 11.54% — and 2025, when it jumped 164.06%.
• Usana Health Sciences' Depreciation & Amortization (CF) stood at $3.3 million in 2022, then dropped by 11.54% to $2.9 million in 2023, then jumped by 37.33% to $4.0 million in 2024, then jumped by 98.02% to $7.9 million in 2025, then climbed by 4.52% to $8.3 million in 2026.
• Business Quant data shows USNA's Depreciation & Amortization (CF) at $8.3 million in Q2 2026, $8.6 million in Q1 2026, and $7.9 million in Q3 2025.